Healthtech

Market Context

Healthtech is experiencing a structural shift from point solutions to AI-native infrastructure, with capital flooding into administrative automation, care navigation, and preventive health simultaneously. The sector logged $2.28B across 57 deals in the past 28 days — a velocity score of 1.8 that places it among the fastest-rising themes on Teahose — driven by a convergence of AI agent adoption across revenue cycle management, prior authorization, and patient-facing clinical workflows. Major strategic moves, including Johnson & Johnson's $1B acquisition of Firefly Bio and Medtronic's $650M purchase of SPR Therapeutics, signal that incumbents are racing to buy what they can't build fast enough.

Investment Activity

• Fabric Health raised a $60M Series A led by General Catalyst, powering seamless multi-setting patient care experiences.
• Hippocratic AI raised $53M co-led by General Catalyst and Andreessen Horowitz, backing its autonomous AI agent platform for non-diagnostic patient-facing services.
• ForSight Robotics raised $55M Series A led by Eclipse Ventures (with The Adani Group and Mithril Capital) for its ORYOM fully robotic cataract surgery platform.
• Nourish raised a $100M Series C led by Menlo Ventures, scaling its NYC-based metabolic health platform.
• Garner Health raised a $100M Series E at a $2.74B valuation, cementing AI-driven care navigation for employers.
• Aidoc secured $150M in Series E funding for its AI-powered clinical decision support platform.
• Ilant Health raised a $15M Series A (Felicis, Bain Capital) for obesity treatment and weight management.
• Lucis raised a $20M Series A led by Singular (with General Catalyst and Y Combinator) for its AI-powered preventive health platform analyzing 110+ blood biomarkers.
• Parallel raised $20M Series A led by Index Ventures to automate medical coding with AI agents.
• Eyebot raised $20M Series A from General Catalyst for its 90-second vision-test kiosk.
• Amperos Health raised $16M Series A from Bessemer Venture Partners to automate healthcare denial management end-to-end.
• Alife Health raised a $9.5M seed from Lux Capital to apply AI to IVF and fertility care.
• ClearNote Health raised its round (part of $185M+ total funding) for noninvasive blood-based early cancer detection.

Key Players

• General Catalyst is the single most active investor in healthtech with 15 deals in 28 days, backing companies across care delivery (Fabric Health), AI agents (Hippocratic AI), diagnostics (Eyebot), benefits infrastructure (Thatch), and financial OS layers (Phare Health) — while its operating company HATCo runs Summa Health as a live AI-native hospital proof-of-concept.
• Hippocratic AI has completed over 115 million clinical patient interactions and raised $404M total at a $3.5B valuation, making it the leading autonomous AI agent platform for patient-facing healthcare services.
• Garner Health achieved a $2.74B valuation on its $100M Series E, using AI models that analyze billions of healthcare claims to steer employees toward higher-quality, lower-cost physicians.
• Aidoc locked in $150M in Series E capital to expand its clinical decision support AI, which operates at scale across hospital radiology and emergency workflows.
• ForSight Robotics is advancing ORYOM, the world's first fully robotic cataract surgery platform, backed by a $55M Series A from Eclipse Ventures, Adani Group, and Mithril Capital.

Market Signals

• General Catalyst leads all investors with 15 healthtech deals in 28 days; Andreessen Horowitz follows with 9, reflecting a two-firm concentration of conviction capital in the space.
• Administrative AI — prior authorization (Silna, Coral, Ethermed), medical coding (Parallel), denial management (Amperos Health), and revenue cycle automation (Commure) — is attracting simultaneous multi-firm investment, signaling a consensus that the $260B+ US healthcare administrative waste problem is now addressable at scale.
• Europe is emerging as a secondary hub: Alan (health insurance unicorn, France), Lucis ($20M Series A, Paris), Dentio (Sweden), and Parallel (Index Ventures-backed, France) all show cross-Atlantic momentum.
• Consumer health AI is fragmenting into micro-niches with real traction: Cal AI reached $20–30M ARR and exited for an estimated $50–100M, while Napkin Math and TrakMac each launched on Product Hunt to strong early engagement.
• M&A velocity is accelerating: Johnson & Johnson acquired Firefly Bio for $1B, Medtronic acquired SPR Therapeutics for $650M, Spring Health acquired Alma, Peloton acquired Skop, and Qualtrics acquired Press Ganey Forsta for $6.75B — all within the 28-day window.
• CHOP's delivery of the first personalized CRISPR therapeutic underscores that gene editing is crossing from research into clinical translation, a signal with long-cycle investment implications.